FRONTIER CAPITAL MANAGEMENT CO LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$4,066,000
-64.2%
567,066
-29.2%
0.03%
-61.7%
Q1 2019$11,347,000
-65.8%
800,781
-67.3%
0.08%
-69.8%
Q4 2018$33,151,000
-48.1%
2,450,214
-14.8%
0.27%
-34.8%
Q3 2018$63,827,000
+85.3%
2,876,367
+37.1%
0.41%
+68.4%
Q2 2018$34,438,0002,098,6030.24%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders